GOSS
Price
$0.19
Change
-$0.01 (-5.00%)
Updated
Jun 3, 04:59 PM (EDT)
Capitalization
46.49M
69 days until earnings call
Intraday BUY SELL Signals
STTK
Price
$4.76
Change
-$0.11 (-2.26%)
Updated
Jun 3, 04:59 PM (EDT)
Capitalization
373.43M
64 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

GOSS vs STTK

Header iconGOSS vs STTK Comparison
Open Charts GOSS vs STTKBanner chart's image
GOSS vs STTK Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
GOSS vs. STTK commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GOSS is a Hold and STTK is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 03, 2026
Stock price -- (GOSS: $0.20 vs. STTK: $4.87)
Brand notoriety: GOSS and STTK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GOSS: 117% vs. STTK: 157%
Market capitalization -- GOSS: $46.49M vs. STTK: $373.43M
GOSS [@Biotechnology] is valued at $46.49M. STTK’s [@Biotechnology] market capitalization is $373.43M. The market cap for tickers in the [@Biotechnology] industry ranges from $107.89B to $0. The average market capitalization across the [@Biotechnology] industry is $1.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GOSS’s FA Score shows that 0 FA rating(s) are green whileSTTK’s FA Score has 0 green FA rating(s).

  • GOSS’s FA Score: 0 green, 5 red.
  • STTK’s FA Score: 0 green, 5 red.
According to our system of comparison, STTK is a better buy in the long-term than GOSS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GOSS’s TA Score shows that 6 TA indicator(s) are bullish while STTK’s TA Score has 4 bullish TA indicator(s).

  • GOSS’s TA Score: 6 bullish, 2 bearish.
  • STTK’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, GOSS is a better buy in the short-term than STTK.

Price Growth

GOSS (@Biotechnology) experienced а -9.05% price change this week, while STTK (@Biotechnology) price change was -20.29% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.54%. For the same industry, the average monthly price growth was -1.96%, and the average quarterly price growth was +3.26%.

Reported Earning Dates

GOSS is expected to report earnings on Aug 11, 2026.

STTK is expected to report earnings on Aug 06, 2026.

Industries' Descriptions

@Biotechnology (-1.54% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
STTK($373M) has a higher market cap than GOSS($46.5M). STTK YTD gains are higher at: 33.425 vs. GOSS (-93.545). STTK has higher annual earnings (EBITDA): -49.02M vs. GOSS (-145.74M). GOSS has more cash in the bank: 180M vs. STTK (90.4M). STTK has less debt than GOSS: STTK (2.89M) vs GOSS (203M). GOSS has higher revenues than STTK: GOSS (44.1M) vs STTK (1M).
GOSSSTTKGOSS / STTK
Capitalization46.5M373M12%
EBITDA-145.74M-49.02M297%
Gain YTD-93.54533.425-280%
P/E RatioN/AN/A-
Revenue44.1M1M4,410%
Total Cash180M90.4M199%
Total Debt203M2.89M7,027%
FUNDAMENTALS RATINGS
GOSS: Fundamental Ratings
GOSS
OUTLOOK RATING
1..100
11
VALUATION
overvalued / fair valued / undervalued
1..100
48
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
97
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
26

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GOSSSTTK
RSI
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 3 days ago
88%
MACD
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 6 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 9 days ago
85%
Bullish Trend 9 days ago
85%
Declines
ODDS (%)
Bearish Trend 7 days ago
87%
Bearish Trend 2 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
74%
Aroon
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
GOSS
Daily Signal:
Gain/Loss:
STTK
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BDHIX9.090.01
+0.11%
BlackRock Dynamic High Income Instl
NAINX9.84N/A
N/A
Virtus Tactical Allocation A
HOORX31.13N/A
N/A
Hartford Schroders US Small Cap Opps R3
FIQAX18.73N/A
N/A
Fidelity Advisor Asset Manager 60% Z
WMIDX11.05N/A
N/A
WCM Mid Cap Quality Value Investor

GOSS and

Correlation & Price change

A.I.dvisor indicates that over the last year, GOSS has been loosely correlated with LITS. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if GOSS jumps, then LITS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GOSS
1D Price
Change %
GOSS100%
+1.01%
LITS - GOSS
46%
Loosely correlated
-15.65%
APVO - GOSS
41%
Loosely correlated
-4.20%
NUVL - GOSS
39%
Loosely correlated
-1.78%
IDYA - GOSS
38%
Loosely correlated
-3.70%
XNCR - GOSS
38%
Loosely correlated
-5.00%
More

STTK and

Correlation & Price change

A.I.dvisor indicates that over the last year, STTK has been loosely correlated with VRTX. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if STTK jumps, then VRTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STTK
1D Price
Change %
STTK100%
-13.81%
VRTX - STTK
36%
Loosely correlated
-3.04%
ADCT - STTK
35%
Loosely correlated
-6.76%
GOSS - STTK
31%
Poorly correlated
+1.01%
TNYA - STTK
31%
Poorly correlated
-9.20%
ZLAB - STTK
30%
Poorly correlated
+0.41%
More